Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus

NCT02633163 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT02633163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02633163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2018
Completion date
February 3, 2026
Enrollment
81 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus